Dr Reddys Laboratories Share Price Today - Live Blog for December 02, 2025

After a -0.08% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,275.25. The stock has a PE ratio of 18.3300, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.15% increase. Presently, it is actively trading at ₹1,275.25.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.03% increase. Presently, it is actively trading at ₹1,273.70.

The stock of Dr Reddys Laboratories Ltd is facing a -0.16% decline and is currently trading at ₹1,272.90 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

After a significant 0.01% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,275.00 in the current market. This upward movement is attracting attention from both retail and institutional investors.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.03%, with its current market value per share resting at ₹1,274.00. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd shares experienced a -0.03% reduction, with the current market price at ₹1,274.60. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.23%. At this moment, it's actively trading at ₹1,276.00, presenting an enticing opportunity for those in the market.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.01% increase. Presently, it is actively trading at ₹1,272.00.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.02%, reaching the current market price of ₹1,271.90. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.13% uptick in its share price. As a result, it's now actively trading at ₹1,271.60 per share, making it an attractive option for investors.

With a -0.26% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,271.00. Investors should examine the factors driving this decline. The stock's PE ratio is 18.3300, whereas the industry PE ratio stands at 33.4846.

Dr Reddys Laboratories Ltd witnessed a substantial 0.26% increase in its share price and is currently trading at ₹1,274.25. This remarkable performance has caught the eye of investors.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.12%, signalling a challenging period. Currently trading at ₹1,270.95, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.15% increase and currently trading at ₹1,272.50 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd displayed price stability, with no changes, and is trading at ₹1,270.00. While the stock's performance remains constant, it's worth noting that its PE ratio is 18.3300, while the industry PE is 33.4846.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.01% upswing, and it's currently trading at ₹1,270.10 per share. Investors are closely watching this development.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.05% drop, and it's now trading at ₹1,270.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.11%, signalling a challenging period. Currently trading at ₹1,270.60, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd share price has declined by -0.12%, and it's currently trading at ₹1,271.20. The stock maintains a PE of 18.3300, while the industry PE is 33.4846, prompting discussions about its valuation.

With a remarkable 0.06% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,271.10. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.3300, while the industry's PE ratio is 33.4846.

Demonstrating a commendable 0.06% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,271.10. In terms of valuation, the stock maintains a PE ratio of 18.3300, while the industry PE ratio stands at 33.4846.

With a -0.06% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,270.40. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.3300, while the industry PE is 33.4846.

Dr Reddys Laboratories Ltd's share price has fallen by -0.44%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,270.35, and market participants are assessing the implications. The stock has a PE ratio of 18.3300, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.65%, reaching the current market price of ₹1,274.50. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a -0.37% decrease, reaching a current market price of ₹1,265.35. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.3300, an ROE of 16.0277% and a debt to equity ratio of 0.1625.